Heart Podcast

Professor Vahanian, Bichat Hospital, Paris, France, is a world leader in management of patients with Valvular Heart Disease and is the lead author of the European Society of Cardiology Guidelines. In this interview, held during the Transcatheter Valve Therapeutics Meeting in Vancouver, Canada in June 2014, Professor Vahanian talks with Catherine Otto about the current approach to patient selection for transcatheter aortic valve implantation (TAVI). The availability of TAVI has transformed our approach to the elderly or high risk patient with severe aortic stenosis and the use of this technology continues to expand as technical issues are resolved and more data on valve durability is published. Clinicians will want to keep up to date on the latest information so appropriate patients are referred for this life saving treatment. To read more about transcatheter aortic valve implantation, see several recent articles in Heart: Predictive factors of early mortality after transcatheter aortic valve implantati